Admission Date:  [**2146-6-27**]              Discharge Date:   [**2146-7-3**]  Date of Birth:  [**2075-8-18**]             Sex:   M  Service: CARDIOTHORACIC  Allergies: Codeine / Doxycycline  Attending:[**Known firstname 922**] Chief Complaint: shoulder pain  Major Surgical or Invasive Procedure: [**2146-6-27**] - Coronary artery bypass graft x 5, with left internal mammary artery to left anterior descending coronary artery, reversed single saphenous vein graft from the aorta to the posterior descending coronary artery, reversed single saphenous vein graft from the aorta to the first obtuse marginal coronary artery, reversed single saphenous vein graft from the aorta to the ramus coronary artery, as well as reversed single saphenous vein graft from the aorta to the first diagonal coronary artery.
Based on his findings and his medical history of diabetes and hypertension as well as hypercholesterolemia, it was recommended he undergo coronary artery bypass graft.
He had a brother who underwent CABG at 59 and died one year later.
[**2146-6-29**] CXR The patient is after median sternotomy and CABG.
[**2146-7-3**] 07:05AM BLOOD  WBC-8.5 RBC-3.51* Hgb-10.1* Hct-31.0* MCV-88 MCH-28.8 MCHC-32.7 RDW-15.5 Plt Ct-313  [**2146-7-3**] 07:05AM BLOOD  PT-19.1* INR(PT)-1.8*  [**2146-7-2**] 07:15AM BLOOD  Glucose-99 UreaN-13 Creat-0.7 Na-140 K-4.0 Cl-106 HCO3-23 AnGap-15  [**2146-7-1**] 09:09PM  URINE Color-Yellow Appear-Clear Sp [**Last Name (un) **]-1.013 URINE Blood-NEG Nitrite-NEG Protein-NEG Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-8.0 Leuks-NEG  Brief Hospital Course: Mr. [**Known lastname **] was admitted to the [**Hospital1 18**] on [**2146-6-27**] for surgical management of his coronary artery disease.
He was taken directly to the operating room where he underwent coronary artery bypass grafting to five vessels.
Beta blockade, aspirin and a statin were resumed.
He is on coumadin 3 mg [**Doctor Last Name **].
Coumadin 3 mg is given q night.
Medications on Admission: HCTZ 25mg QD Lisinopril 5mg QD Aspirin 325mg QD Lipitor 40mg QD Toprol XL 50mg QD  Discharge Medications: 1.
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
Ferrous Sulfate 325 mg (65 mg Iron) Tablet Sig: One (1) Tablet PO DAILY (Daily) for 1 months.
Ascorbic Acid 500 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) for 1 months.
Hydromorphone 2 mg Tablet Sig: One (1) Tablet PO Q3H (every 3 hours) as needed for pain.
Ranitidine HCl 150 mg Tablet Sig: One (1) Tablet PO once a day for 1 months.
Aspirin 81 mg Tablet, Delayed Release (E.C.)
Atorvastatin 40 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Amiodarone 200 mg Tablet Sig: Two (2) Tablet PO BID (2 times a day): please take 400mg twice a day, on [**7-7**] decrease to 400 mg daily, then decrease to 200mg [**7-14**] and follow up with Dr [**Last Name (STitle) **].
Furosemide 20 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) for 4 days.
Cephalexin 500 mg Capsule Sig: One (1) Capsule PO Q6H (every 6 hours) for 10 days.
Potassium Chloride 20 mEq Packet Sig: One (1) Packet PO Q12H (every 12 hours) for 5 days.
Coumadin 3 mg Tablet Sig: One (1) Tablet PO once a day: INR goal is [**3-13**].
Metoprolol Tartrate 25 mg Tablet Sig: Three (3) Tablet PO TID (3 times a day).
Disp:*270 Tablet(s)* Refills:*3*   Discharge Disposition: Home With Service  Facility: [**Hospital 119**] Homecare  Discharge Diagnosis: CAD s/p CABGx5 HTN Hyperlipidemia Diet controlled diabetes Afib   Discharge Condition: Good   Discharge Instructions: 1)  Monitor wounds for signs of infection.
These include redness, drainage or increased pain.
4)  No lotions, creams or powders to incision until it has healed.
Use sunscreen on incision if exposed to sun.
7) Call with any questions or concerns [**Telephone/Fax (1) 170**]  8) Pt/INR for coumadin dosing Dr [**Last Name (STitle) **] will follow your INR.
3) Medications: drug interactions reviewed, emphasizing the need to notify ACMS of any changes in use of prescription or OTC medications (including acetaminophen) and avoidance of NSAIDS/ASA containing drugs.
Specifically requested patient to notify ACMS of any addition of OTC/herbals/supplements/prescription drugs so that potential warfarin interactions may be investigated.
4) Dietary considerations: reviewed vitamin K's intraction with warfarin.
Stressed the importance of consistency in weekly diet, [**Location (un) 1131**] food labels for ingredients, serving sizes of vitamin K [**Doctor First Name **] foods, avoidance of nutritional supplements and multivitamins containing vitamin K.  5) Alcohol use: Explained interaction with warfarin, potential increased bleeding risk associated with alcohol intake, importance of communicating changes in alcohol intake pattern with ACMS providers.
Advised patient to carry Anticoagulation ID card and /or Medic Alert ID.
Emphasized the need to notify all providers of warfarin therapy and ACMS of upcoming procedures and any dosage recommendations made by other providers.
Reviewed potential tetrogenic effects of warfarin on the fetus.
